Hector Armando Kellum, Sandoz' former US vice-president of business contracting and analytics, has admitted his part in a conspiracy to “fix prices, rig bids, and allocate customers for generic drugs,” according to the US Department of Justice.
Announcing Kellum’s guilty plea, the DoJ said that court documents indicated that these activities took place “from at least March 2013 until at least June 2015,” while he was at Sandoz, and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?